医学
外科
坏死性胰腺炎
胰腺炎
优势比
经皮
单变量分析
置信区间
胰瘘
内科学
胰腺
多元分析
作者
Nihar Mohapatra,Shridhar Vasantrao Sasturkar,Sanyam Falari,Rommel Sandhyav,Niteen Kumar,Nikhil Agrawal,Asit Arora,Viniyendra Pamecha,Tushar Kanti Chattopadhyay
摘要
Abstract Background Minimally invasive retroperitoneal necrosectomy has been an integral component of ‘step‐up’ approach for infected pancreatic necrosis. Even though the clinical outcome of nephroscopic necrosectomy has been studied earlier, its predictor and morbidities following surgery have not been extensively evaluated. We aimed to evaluate the clinical outcome and early and late complications after percutaneous nephroscopic necrosectomy (PCNN). Methods The pre‐ and intra‐operative as well as post‐operative and follow‐up data of severe pancreatitis patients undergoing PCNN were collected prospectively. Results Out of 115 patients requiring intervention, 40 patients (34.78%) improved with percutaneous drain alone and another 40 proceeded for PCNN. After exclusion, 37 patients successfully underwent 48 sessions of PCNN. Median number of PCNN session was 1 (1–4). Early complications were seen in 21 (56.75%) patients and mortality was experienced in eight (21.62%) patients. On median follow‐up of 36 months, 12 (32.43%) patients experienced late complications. Persistent post‐operative pancreatic fistula was observed in six (16.21%) patients. Of these, three developed late‐onset pseudocyst, whereas one patient had disconnected duct syndrome. Seven patients experienced new‐onset diabetes. Age, severity of pancreatitis, preoperative organ failure and multiorgan failure were significant predictors of mortality on univariate analysis ( P ≤ 0.05 for each). The logistic regression analysis revealed presence of multiorgan failure before surgery as the sole predictor ( P = 0.007; odds ratio 10.417; 95% confidence interval 1.759–61.672). Conclusion Preoperative multiorgan failure was the most important predictor of mortality following PCNN. Late complications were seen in nearly one‐third of patients emphasizing the need for long‐term follow‐up.
科研通智能强力驱动
Strongly Powered by AbleSci AI